|
2024
|
P/S
|
Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clin... |
|
2023
|
P/S
|
Medical devices for neutralizing chemical agents and toxins; injection device for pharmaceuticals... |
|
2022
|
P/S
|
Pharmaceutical preparations for the treatment and prophylaxis of biological infection, exposure, ... |
|
2021
|
P/S
|
DOWNLOADABLE DIGITAL MARKETING MATERIAL, NAMELY, DOWNLOADABLE ELECTRONIC PUBLICATIONS IN THE NATU... |
|
2020
|
P/S
|
Downloadable digital marketing material, namely, downloadable electronic publications in the natu... |
|
2015
|
P/S
|
contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clin... |
|
2014
|
Invention
|
Stable anthrax vaccine formulations.
Formulations of anthrax protective antigen are provided tha... |
|
2013
|
P/S
|
Pharmaceutical preparations for the treatment and prophylaxis of infections, of exposure to harmf... |
|
|
P/S
|
Pharmaceutical preparations, including pharmaceutical preparations for the treatment and prophyla... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prophylaxis of: biological infection, exposure,... |
|
2009
|
Invention
|
Use of e. coli surface antigen 3 sequences for the export of heterologous antigens. The present i... |
|
|
Invention
|
Vaccines against clostridium difficile and methods of use. Attenuated microorganisms expres... |
|
|
Invention
|
Vaccines against clostridium difficile and methods of use. Attenuated microorganisms expressing C... |
|
|
Invention
|
Stable anthrax vaccine formulations. Formulations of anthrax protective antigen are provided that... |
|
|
Invention
|
Fermentation method for the production of soluble botulinum neurotoxin proteins. A method is prov... |
|
2008
|
Invention
|
Botulinum neurotoxin vaccine. The invention provides compositions comprising an antigenic botulin... |
|
|
Invention
|
Chemically modified peptides with improved immunogenicity. The invention provides processes for i... |
|
|
P/S
|
Pharmaceutical preparations, namely, anthrax vaccine. |
|
2006
|
Invention
|
Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents. Antimicrobial compounds, compos... |
|
|
P/S
|
Pharmaceutical preparations, namely vaccines, immunotherapeutics and biologics for prophylactic a... |
|
|
P/S
|
Pharmaceutical preparations, namely, vaccines, immunotherapeutics and biologics, immunobiotics fo... |
|
|
Invention
|
Proteins with improved solubility and methods for producing and using same. A method is provided ... |
|
|
P/S
|
Pharmaceutical preparations, namely, vaccines and biologics for prophylactic therapeutic purposes... |
|
|
P/S
|
Pharmaceutical preparations, namely vaccines, immunotherapeutics, biologics and immunobiotics for... |
|
|
P/S
|
Pharmaceutical preparations, namely vaccines, immunotherapeutics and biologics, immunobiotics for... |
|
2005
|
P/S
|
Pharmaceutical preparations, namely anthrax vaccines. |
|
|
P/S
|
Pharmaceutical preparations, namely, vaccines, immunotherapeutics, biologics, and immunobiotics f... |
